The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
OPTIMA prelim: Optimal personalized treatment of early breast cancer using multiparameter tests.
Rob Stein
Honoraria - Genomic Health
Andreas Makris
Honoraria - Genomic Health
Luke Hughes-Davies
No relevant relationships to disclose
Amy Frances Campbell
No relevant relationships to disclose
Andrea Marshall
No relevant relationships to disclose
John M. S. Bartlett
Consultant or Advisory Role - GE Healthcare; Genoptix
Honoraria - Genomic Health
Research Funding - HistoRX
Jenny Donovan
No relevant relationships to disclose
Christopher McCabe
No relevant relationships to disclose
David A. Cameron
Honoraria - Genomic Health
Peter Canney
No relevant relationships to disclose
Adele Francis
Honoraria - Genomic Health
Adrienne Morgan
No relevant relationships to disclose
Sarah Pinder
No relevant relationships to disclose
Daniel Rea
Honoraria - Genomic Health
Peter Hall
Honoraria - Clarient
Nigel Stallard
No relevant relationships to disclose
Helen B Higgins
No relevant relationships to disclose
Claire Hulme
No relevant relationships to disclose
Victoria Harmer
No relevant relationships to disclose
Janet A. Dunn
No relevant relationships to disclose